Nutex Health is rated Buy, with a DCF-based price target of $199.31, offering 19.8% upside from $166.40. NUTX's revenue ...
The migration of Taiwan’s semiconductor supply chain into the United States is no longer a trend in early formation; it is an industrial realignment already in motion. A growing body of opportunity is ...
In the Gulf, the SAR intelligence market is worth up to $2bn annually, part of a global sector expected to reach nearly $10bn by 2030, says the Space42 exec ...
According to RTA, the works have been strategically scheduled during the summer holiday period to take advantage of lower traffic volumes ...